Support from a network of leading researchers across Europe specialised in a rare auto-immune disease with unmet medical needs could help test several novel treatments

A new type of high-sensitivity and low-cost sensors, called plasmonic biosensors, could ultimately become a key asset in personalised medicine by helping to diagnose diseases at an early stage 

New virus serotypes are safely used as ‘DNA transporters’ to successfully deliver genes to deficient cells. 

Metabolites found in our blood are linked to ageing and can signpost the risk of developing age-related diseases. This may help avoid such risks and reduce the rate at which we age biologically.

A promising new approach to gene therapy for neurodegenerative diseases makes use of an unexpected virus as the agent of delivery. 

Regenerating bones based on a mixture of tissue engineering approaches is coming of age.

The genetics of fruit flies helps researchers to identify new targets for cancer therapy and to develop more individualised treatments.

Next-generation antimalarial drugs are much needed to address resistance issues to current treatments. New strategies may work by interfering with the biology of the parasite causing the disease. 

Intervertebral disc degeneration can result in back pain. Now a team of scientists is debunking the myth that excessive physical work is the main culprit, and is looking at other causes.